Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Carisma Therapeutics Inc. (SESN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2023 |
8-K/A
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data|
Docs:
|
"Consent of Independent Registered Public Accounting Firm",
"Carisma Therapeutics Inc. INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Consolidated Financial Statements Report of Independent Registered Public Accounting Firm F-2 Consolidated Balance Sheets, December 31, 2022 and 2021 F-3 Consolidated Statements of Operations and Comprehensive Loss, Years Ended December 31, 2022 and 2021 F-4 Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit, Years ended December 31, 2022 and 2021 F-5 Consolidated Statements of Cash Flows, Years ended December 31, 2022 and 2021 F-6 Notes to Consolidated Financial Statements F-7 F- 1 Report of Independent Registered Public Accounting Firm",
"MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On March 7, 2023, Sesen Bio consummated the merger with Carisma in accordance with the terms of the Agreement and Plan of Merger Reorganization, dated as of September 20, 2022, as amended by the First Amendment thereto dated as of December 29, 2022 and the Second Amendment thereto dated as of February 13, 2023 by and among Carisma and Seahawk Merger Sub, Inc. , pursuant to which, among other matters, Merger Sub merged with and into Carisma, with Carisma continuing as a wholly-owned subsidiary of Sesen Bio and the surviving corporation of the Merger. At which time, Sesen Bio changed its name to “Carisma Therapeutics Inc” . Immediately prior to the execution and delivery of the Merger Agreement, Carisma entered into a subscription ...",
"Carisma Therapeutics Reports Fiscal 2022 Financial Results and Recent Business Highlights" |
|
| 08/11/2022 |
8-K/A
| Quarterly results |
| 05/08/2020 |
8-K/A
| Other Events, Financial Statements and Exhibits |
| 02/26/2020 |
8-K/A
| Quarterly results |
| 08/07/2019 |
8-K/A
| Results of Operations and Financial Condition, Other Events |
| 10/17/2017 |
8-K/A
| Quarterly results |
| 12/06/2016 |
8-K/A
| Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits |
|
|